Related Experiment Videos
A method of conducting therapeutic sessions with MDMA
Abstract:
A method for preparing clients and conducting therapeutic sessions with 3,4-methylenedioxymethamphetamine (MDMA) is described, with emphasis on the need for careful attention to the mental set of therapists and clients and the setting of the session. The therapists' belief was that MDMA inhibited the fear response to a perceived emotional threat, allowing the client to place the emotional sequelae of past experiences into a more realistic perspective in their current emotional lives and relationships. Clients were carefully screened and prepared until they had a clear purpose for the session, including a willingness to experience and to learn from anything that might happen. Sympathomimetic effects of MDMA determined the medical contraindications, and clients with histories of serious functional psychiatric impairments were excluded. Total doses of 75-150 mg, plus 50 mg if requested later, were administered, followed by clients lying down and listening to music with eyeshades and headphones during the peak MDMA effect. Screening and follow-up questionnaires were utilized. Two case histories are presented: a man achieving relief of pain from multiple myeloma, and a woman finding relief from problems as the daughter of Holocaust survivors. Use of consciousness-altering drugs in other contexts is discussed.
Insights
This study details a therapeutic method using 3,4-methylenedioxymethamphetamine (MDMA) to reduce fear responses, aiding clients in processing past experiences. MDMA-assisted therapy showed promise in case studies for pain and trauma relief.
Area of Science:
- Psychiatry
- Psychopharmacology
- Clinical Psychology
Background:
- Therapeutic use of 3,4-methylenedioxymethamphetamine (MDMA) requires careful consideration of therapist/client mindset and session environment.
- MDMA is hypothesized to inhibit fear responses, enabling clients to re-contextualize past emotional experiences.
Observation:
- Clients underwent rigorous screening and preparation, establishing a clear purpose for the MDMA-assisted session.
- Medical contraindications were identified based on MDMA's sympathomimetic effects, excluding individuals with severe psychiatric impairments.
- Standard MDMA dosage (75-150 mg, optional 50 mg booster) was administered, followed by a music-listening protocol during peak effects.
Findings:
- Two case studies illustrate positive outcomes: relief from multiple myeloma pain and resolution of intergenerational trauma from Holocaust survivor experiences.
- Screening and follow-up questionnaires were employed to assess therapeutic progress and client well-being.
Implications:
- This method suggests potential for MDMA-assisted therapy in managing complex psychological conditions and trauma.
- Further research into consciousness-altering drugs in therapeutic contexts is warranted.